LUX biotechnology wins the Pfizer Award for Innovation

23-Nov-2006

LUX biotechnology ltd were named as the recipients of the Pfizer Award for Innovation in Life Sciences for 2006. The award recognizes the results achieved by LUX's research and development and the Company's contribution to enhancing the reputation of the Scottish biotechnology industry. As a specialist developer of detection technologies based on advanced imaging techniques, the company currently markets and develops a range of products including laboratory and diagnostic reagents, chemicals, water contamination monitors, and calibration devices.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures